About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

TAIKO PHARMACEUTICAL CO., LTD.(4574) Summary

4574
TSE Prime
TAIKO PHARMACEUTICAL CO., LTD.
318
JPY
+1
(+0.32%)
Dec 23, 3:30 pm JST
2.03
USD
Dec 23, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
29.0
PBR
1.98
Yield
ー%
Margin Trading Ratio
17.26
Stock Price
Dec 23, 2024
Opening Dec 23, 9:00 am
317 JPY 2.02 USD
Previous Close Dec 20
317 JPY 2.02 USD
High Dec 23, 10:35 am
320 JPY 2.04 USD
Low Dec 23, 3:24 pm
316 JPY 2.01 USD
Volume
140,600
Trading Value
0.05B JPY 0.29M USD
VWAP
317.63 JPY 2.03 USD
Minimum Trading Value
31,800 JPY 203 USD
Market Cap
0.02T JPY 0.10B USD
Number of Trades
218
Liquidity & Number of Trades
As of Dec 23, 2024
Liquidity
Mid
1-Year Average
353
1-Year High Mar 8, 2024
4,721
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 13, 2024 34,500 593,700 17.21
Dec 6, 2024 31,500 568,100 18.03
Nov 29, 2024 28,300 597,400 21.11
Nov 22, 2024 32,100 553,900 17.26
Nov 15, 2024 35,800 554,600 15.49
Company Profile
TAIKO PHARMACEUTICAL CO., LTD. manufactures and sells over-the-counter medicine "Seirogan" and infection control products "Cleverin". The company is expanding its overseas sales.
Sector
Pharmaceuticals